2.  Having previously worked for USAA Marketing, San
Antonio's Dawn Johnson now serves as the chief
executive and founder of DMJ Consulting, a firm
dedicated to developing executive business
strategies that tie all aspects of the business into its
bottom-line results. Dawn Johnson is also involved
with charitable organizations both within San Antonio
and nationally, including the Leukemia & Lymphoma
Society (LLS), where she is a board member.
Committed to curing and preventing blood cancers
for over 60 years, the Leukemia & Lymphoma Society
focuses on leukemia, lymphoma, myeloma, and
Hodgkin’s disease.

3.  In 2014 alone, the nonprofit supported 350 research
projects throughout the world, contributed $79.8
million to research and grants, and spent $15.9 million
on its therapy acceleration program.
A strategic initiative, the LLS therapy acceleration
program helps clinical investigators develop
treatments and craft supportive diagnostics more
quickly than they would otherwise be able to,
through academic concierge services, a
biotechnology accelerator, and clinical trials. Its
academic concierge division uses the organization’s
network of clinical-grade material manufacturing
companies and documentation assembly services to
help studies move into the next development stages.

4.  For companies with active or potential
blood cancer projects, the
biotechnology accelerator secures
funding necessary to complete testing,
registration, and marketing for new
therapies and diagnostics. In the final
component of the therapy acceleration
program, the clinical trials division helps
patients access clinical trial studies in
community oncology settings.